Medications

Developing the first drug for a deadly bone disease

The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation ...

Pediatrics

Understanding and treating pain in children

Go ahead. Try asking a crying child or baby what's wrong, and you most likely will come away as baffled as you were at first wail. This becomes a particular problem in hospitals where assessing pediatric pain and treating ...

Medications

Atezolizumab can induce response in alveolar soft part sarcoma

The immunotherapy agent atezolizumab induces sustained responses in about one-third of patients with advanced alveolar soft part sarcoma (ASPS), according to a study published in the Sept. 7 issue of the New England Journal ...

page 7 from 40